Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis - Chen, Nan; Hao, Chuanming; Peng, Xiaomei; Lin, Hongli; Yin, Aiping; Hao, Li; Tao, Ye; Liang, Xinling; Liu, Zhengrong; Xing, Changying; Chen, Jianghua; Luo, Laimin; et al. (The New England journal of medicine, 2019)
Keywords: Acidosis; Acidosis - chemically induced; Adult; Aged; Anemia; Anemia - drug therapy; Anemia - etiology; Cardiovascular disease; Cholesterol; Cholesterol - blood; Dialysis; Double-Blind Method; Erythropoiesis; Erythropoietin; Female; Glycine - adverse effects; Glycine - analogs & derivatives; Glycine - therapeutic use; Heart failure; Hematinics - adverse effects; Hematinics - therapeutic use; Hemodialysis; Hemoglobin; Hemoglobins - analysis; Hepcidin; Homeostasis; Humans; Hyperkalemia; Hyperkalemia - chemically induced; Hypoxia-Inducible Factor-Proline Dioxygenases - antagonists & inhibitors; Hypoxia-inducible factors; Iron; Isoquinolines - adverse effects; Isoquinolines - therapeutic use; Kidney diseases; Male; Metabolic acidosis; Metabolism; Middle Aged; Patients; Prolyl hydroxylase; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - complications; China